Zachary Laidley, DPM
Podiatrist · Edmonds, WANPI 1639668833
Payments from drug & device makers
What this record shows
14 manufacturers reported payments, led by Paragon 28, Inc. at 49.7% of the total. Reporting peaked in 2024 at $1,971 and has fallen 88.1% since, to $234 in 2025.
Across 35 payments — averaging $113.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$2K
- Stryker$1K
- Orthofix Medical, Inc.$156
- Amgen$141
- Heron Therapeutics, Inc.$125
- Smith+Nephew$49
- plus $245 from 8 others
What the payments were for
- Travel & lodging$2,27857%
- Food & beverage$1,69943%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 11 | $1,976 |
| Stryker | 9 | $1,286 |
| Orthofix Medical, Inc. | 2 | $156 |
| Amgen(2 entities) | 2 | $141 |
| Heron Therapeutics, Inc. | 1 | $125 |
| Smith+Nephew | 1 | $49 |
| Summit Surgical Corp. | 1 | $49 |
| Bioventus LLC | 2 | $39 |
| Voom Medical Devices, Inc. | 1 | $39 |
| Anika Therapeutics, Inc. | 1 | $32 |
| Solventum Corporation | 1 | $24 |
| Fusion Orthopedics USA, LLC | 1 | $23 |
| Integra Lifesciences Corporation | 1 | $20 |
| Avanos Medical | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Portfolio$1,390
- INBONE$1,010
- APEX 3D$369
- Physio-Stim$138
- PARATROOPER$128
- KRYSTEXXA$125
- Zynrelef$125
How this compares
$3,977 in reported general payments places this provider in the 80th percentile of 134 podiatrist providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 12 | $202 |
| Gabapentin | 16 | $202 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $128 |
| Methylprednisolone | 14 | $127 |
| Mupirocin | 11 | $104 |
| Oxycodone Hcl | 16 | $69 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Edmonds
- Byron HutchinsonBurien$903K
- Michael DujelaCentralia$99K
- Huy DangCentralia$63K
- Michael FrazierFederal Way$27K
- Ryan StoneBurien$15K
- Alvin NganSeattle$13K
- Tony KimWenatchee$11K
- Anthony MollicaBellevue$11K
- Todd ChappellTacoma$9K
- Matthew WilliamsSeattle$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.